Abiopharma

ResMed Inc. Daily Stock Update

Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025

UTHR: Notification

Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones

Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis

Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST

UTHR: Notification

XOMA Royalty Enters into Agreement to Acquire Generation Bio

XOMA Royalty Enters into Agreement to Acquire Generation Bio